SG11202006539RA - Cytocidal agent - Google Patents
Cytocidal agentInfo
- Publication number
- SG11202006539RA SG11202006539RA SG11202006539RA SG11202006539RA SG11202006539RA SG 11202006539R A SG11202006539R A SG 11202006539RA SG 11202006539R A SG11202006539R A SG 11202006539RA SG 11202006539R A SG11202006539R A SG 11202006539RA SG 11202006539R A SG11202006539R A SG 11202006539RA
- Authority
- SG
- Singapore
- Prior art keywords
- cytocidal agent
- cytocidal
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018001063 | 2018-01-09 | ||
| PCT/JP2018/048523 WO2019138944A1 (en) | 2018-01-09 | 2018-12-28 | Cytocide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006539RA true SG11202006539RA (en) | 2020-08-28 |
Family
ID=67219047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006539RA SG11202006539RA (en) | 2018-01-09 | 2018-12-28 | Cytocidal agent |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11191804B2 (en) |
| EP (1) | EP3738602B1 (en) |
| JP (1) | JP7195621B2 (en) |
| KR (1) | KR102510514B1 (en) |
| CN (1) | CN111556758B (en) |
| AU (1) | AU2018402356B2 (en) |
| CA (1) | CA3087744A1 (en) |
| SG (1) | SG11202006539RA (en) |
| WO (1) | WO2019138944A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114560913A (en) * | 2021-12-15 | 2022-05-31 | 中国地质大学（武汉） | Polypeptide probe for cancer treatment and preparation method and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| KR100784187B1 (en) * | 2003-04-21 | 2007-12-10 | 히데아키 시마다 | Apoptosis Inducing Agent and Method of Inducing Apoptosis |
| CN103435683B (en) * | 2006-06-16 | 2016-02-03 | 肿瘤疗法·科学股份有限公司 | Cancer rejection antigen peptide from SPARC and the medicine containing this peptide |
| EP2515944B1 (en) * | 2009-12-23 | 2020-04-22 | Sanford-Burnham Medical Research Institute | Methods and compositions related to annexin 1-binding compounds |
| US9783576B2 (en) | 2013-06-11 | 2017-10-10 | Sanford-Burnham Medical Research Institute | Compositions and methods for targeted endometriosis treatment |
| AU2015366284B2 (en) * | 2014-12-19 | 2021-07-22 | Ablynx N.V. | Cysteine linked nanobody dimers |
| RU2571551C1 (en) * | 2015-04-16 | 2015-12-20 | Закрытое акционерное общество "ПЕПТЕК" | Specific combined therapy of malignant tumours with cytostatic agent and its modifying agent |
| KR20160145308A (en) | 2015-06-10 | 2016-12-20 | 대덕대학산학협력단 | advanced concept doorlock |
| JP2018001063A (en) | 2016-06-28 | 2018-01-11 | Jnc株式会社 | Filter medium and manufacturing method of the same |
| JP6613499B2 (en) | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | Cell killing agent |
-
2018
- 2018-12-28 KR KR1020207019468A patent/KR102510514B1/en active IP Right Grant
- 2018-12-28 EP EP18899050.1A patent/EP3738602B1/en active Active
- 2018-12-28 AU AU2018402356A patent/AU2018402356B2/en active Active
- 2018-12-28 US US16/960,417 patent/US11191804B2/en active Active
- 2018-12-28 CN CN201880085530.7A patent/CN111556758B/en active Active
- 2018-12-28 CA CA3087744A patent/CA3087744A1/en active Pending
- 2018-12-28 JP JP2019564657A patent/JP7195621B2/en active Active
- 2018-12-28 WO PCT/JP2018/048523 patent/WO2019138944A1/en active Search and Examination
- 2018-12-28 SG SG11202006539RA patent/SG11202006539RA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200330549A1 (en) | 2020-10-22 |
| JP7195621B2 (en) | 2022-12-26 |
| US11191804B2 (en) | 2021-12-07 |
| EP3738602B1 (en) | 2023-03-15 |
| AU2018402356A1 (en) | 2020-07-30 |
| AU2018402356B2 (en) | 2021-05-20 |
| JPWO2019138944A1 (en) | 2021-03-04 |
| CA3087744A1 (en) | 2019-07-18 |
| EP3738602A4 (en) | 2021-10-13 |
| CN111556758B (en) | 2023-12-29 |
| KR102510514B1 (en) | 2023-03-14 |
| EP3738602A1 (en) | 2020-11-18 |
| CN111556758A (en) | 2020-08-18 |
| KR20200096603A (en) | 2020-08-12 |
| WO2019138944A1 (en) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201709456D0 (en) | Therapeutic agents | |
| GB201814169D0 (en) | Blockchain autonoumous agents | |
| GB201814281D0 (en) | Cytotoxic agents | |
| GB201714115D0 (en) | Cytotoxic agents | |
| IL269239A (en) | Pharmaceutical combination comprising ponesimod | |
| IL262623A (en) | Tourniquet | |
| GB201913756D0 (en) | Contrast agent | |
| SG11202001484QA (en) | Cytocidal agent | |
| GB201700553D0 (en) | Therapeutic agents | |
| GB201714777D0 (en) | Agent | |
| SG11202006539RA (en) | Cytocidal agent | |
| GB201807050D0 (en) | Medical uses | |
| GB201807046D0 (en) | Combination | |
| GB201801634D0 (en) | # | |
| SG10202108899XA (en) | Anti-inflammatory agent | |
| ZA202103578B (en) | Dna-cutting agent | |
| ZA202103582B (en) | Dna-cutting agent | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| GB201820829D0 (en) | Anti-mycobacterial agents | |
| GB201917205D0 (en) | Use | |
| GB201916691D0 (en) | Use | |
| GB201812657D0 (en) | Inhibitory agent | |
| PL3740638T3 (en) | Functional unit | |
| GB201807887D0 (en) | Combination | |
| GB201803525D0 (en) | Combination |